ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

ClinicalTrials.gov ID: NCT01144637

Public ClinicalTrials.gov record NCT01144637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-Naïve Subjects

Study identification

NCT ID
NCT01144637
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bavarian Nordic
Industry
Enrollment
4,005 participants

Conditions and interventions

Conditions

Interventions

  • IMVAMUNE® Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2013
Primary completion
Oct 31, 2013
Completion
May 31, 2014
Last update posted
Jan 2, 2019

2013 – 2014

United States locations

U.S. sites
34
U.S. states
24
U.S. cities
34
Facility City State ZIP Site status
Alabama Vaccine Research Clinic Birmingham Alabama 35294
Anaheim Clinical Trials Anaheim California 92801
National Research Institute Los Angeles California 90057
Northern California Clinical Research Center (NCCRC) Redding California 96001
Therapeutics Clinical Research San Diego California 92123
Lynn Institute of the Rockies Colorado Springs Colorado 80907
Avail Clinical Research, LLC DeLand Florida 32720
Broward Research Group Hollywood Florida 33024
Accelovance Melbourne Melbourne Florida 32935
Southeast Regional Research Group Savannah Georgia 31405
Advanced Clinical Research, Inc. Meridian Idaho 83642
Accelovance Peoria Peoria Illinois 61602
Heartland Research Associates Augusta Kansas 67010
Heartland Research Associates, LLC Wichita Kansas 67207
Benchmark Research Metairie Louisiana 70006
QPS Bio-Kinetic Springfield Missouri 65802
Washington University in St. Louis, School of Medicine St Louis Missouri 63110
Meridian Clinical Research, LLC Omaha Nebraska 68134
Clinical Research Center of Nevada, LLC Las Vegas Nevada 89104
Rochester Clinical Research, Inc. Rochester New York 14609
Wake Research Associates Raleigh North Carolina 27612
Rapid Medical Research, Inc. Cleveland Ohio 44122
Family Practice Center of Wooster Wooster Ohio 44691
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Columbia Research Group, Inc. Portland Oregon 97239
Omega Medical Research Warwick Rhode Island 02886
PMG Research of Charleston Mt. Pleasant South Carolina 29464
Holston Medical Group Bristol Tennessee 37620
Volunteer Research Group Knoxville Tennessee 37920
Benchmark Research Fort Worth Texas 76135
Tanner Clinic Layton Utah 84041
Advanced Clinical Research West Jordan Utah 84088
Clinical Research Associates of Tidewater Norfolk Virginia 23507
University Physicians Internal Medicine University Physicians & Surgeons, Inc. Huntington West Virginia 25701

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01144637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 2, 2019 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01144637 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →